T2EVOLVE thanks everyone for joining us at our roundtable discussion at the Deutsche Gesellschaft für Gentherapie e.V. (DG-GT) workshop, in Langen, Germany last week.

The sessions discussing how we progress the parent-child IND concept from a regulatory point of view was enriched by a diverse range of panelists from industry, regulatory bodies, and academia.

We look forward to continuing the dialogue on the subject.

To revisit the DG-GT meeting and its sessions, please see the event website:


Share This